project id: TCGA-BRCA; case submitter id: TCGA-B6-A401; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.77; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.31; rna integrity number: 8.1; age at index: 47; days to birth: -17438; ethnicity: not hispanic or latino; gender: female; race: black or african american; vital status: Alive; year of birth: 1960; age at diagnosis: 17438; ajcc pathologic m: M0; ajcc pathologic n: N1a; ajcc pathologic stage: Stage IIA; ajcc pathologic t: T1c; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 2596.0; icd 10 code: C50.9; last known disease status: not reported; morphology: 8500/3; primary diagnosis: Infiltrating duct carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Breast, NOS; synchronous malignancy: No; tissue or organ of origin: Breast, NOS; tumor grade: Not Reported; year of diagnosis: 2007; treatment or therapy: yes; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 1935; initial weight: 30.0; sample id: 4c932085-e46b-4544-a32c-c38b2bac837a; sample submitter id: TCGA-B6-A401-01A; portion id: 68ebcd25-93de-456e-896f-b62fef53a112; portion submitter id: TCGA-B6-A401-01A-11; slide id: c196d55b-479e-4f08-a6bb-c5f8fda2113e; slide submitter id: TCGA-B6-A401-01A-01-TS1; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 8.0; percent stromal cells: 2.0; percent tumor cells: 90.0; percent tumor nuclei: 85.0; section location: TOP;